Author

Kazuaki Kakehi

Post doc University of Bern - Cited by 420 - AAV gene therapy

Biography

Dr. Kazuaki Kakehi obtained his PhD degree at Osaka University (Osaka, Japan) in 1975, and is professor of School of pharmacy, Kinki University (Higashi-Osaka, Japan). At the initial step of his carrier, he was interested in synthetic chemistry of glycans, and succeeded in the synthesis of homo-oligosaccharides of 1-6 glucans. Then, he has been developing various methods for quantitative analysis of carbohydrates using GC, HPLC, CE, and microchip electrophoresis. 
Title
Cited by
Year
HDAC1 regulates fear extinction in mice
S Bahari-Javan, A Maddalena, C Kerimoglu, J Wittnam, T Held, M Bähr, ...Journal of Neuroscience 32 (15), 5062-5073, 2012201
202
2012
Triple vectors expand AAV transfer capacity in the retina
A Maddalena, P Tornabene, P Tiberi, R Minopoli, A Manfredi, M Mutarelli, ...Molecular Therapy 26 (2), 524-541, 2018201
100
2018
Adeno-associated virus-mediated, mifepristone-regulated transgene expression in the brain
A Maddalena, J Tereshchenko, M Bähr, S KüglerMolecular Therapy-Nucleic Acids 2, 2013201
36
2013
High-throughput screening identifies kinase inhibitors that increase dual AAV vectors transduction in vitro and in mouse retina.
A Maddalena, F Dell’Aquila, P Giovannelli, P Tiberi, L Wanderlingh, ...HUMAN GENE THERAPY, 20820
1
2018
500. Triple AAV Vectors Expand AAV Cargo Capacity in the Retina
A Maddalena, P Colella, I Trapani, R Minopoli, A AuricchioMolecular Therapy 23, S200, 20520
1
2015

Referred From: https://scholar.google.com/citations?user=-s5FUFEAAAAJ&hl=en

Cited by
Citations 420
h-index 5
i10-index 4
Recommended Journals
Open Access Journals